Department of Dermatology, Jagiellonian University Medical College, Kopernika 50, 31-501 Krakow, Poland.
Department of Pathophysiology and Allergy Research, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
Medicina (Kaunas). 2021 Oct 19;57(10):1133. doi: 10.3390/medicina57101133.
Chronic spontaneous urticaria (CSU) is a distressing skin condition, which manifests as red, swollen, itchy, and sometimes painful hives or wheals appearing on skin. Recently, CSU has been associated with bradykinin release, which was previously discovered to be the main trigger of hereditary angioedema attacks. To study the role of bradykinin receptors 1 (BR1) and 2 (BR2) in the etiopathogenesis of CSU. A total of 60 individuals, 30 patients with CSU and 30 healthy subjects, were recruited to the study. CSU was diagnosed in accordance with the standardized protocol of dermatological assessment of skin symptoms. The level of bradykinin receptors was determined in populations of CD3, CD4, and CD8 lymphocytes as well as in CD14CD16, CD14CD16 and CD14CD16 monocytes. In addition, urticaria activity score summed over 7 days (UAS-7) was assessed and correlated with BR1 and BR2 expression. A statistically significant higher concentration of BR1 expression in lymphocytes was found in patients with CSU, compared to the control group ( < 0.001). Moreover, a statistically significant positive correlation was observed between UAS-7 and BR1/BR2 expression in CD14CD16 cells ( = 0.03, R = 0.4). : Bradykinin receptors are elevated in selected populations of lymphocytes in symptomatic CSU patients compared to healthy controls, indicating their role in the etiopathogenesis of the disease.
慢性自发性荨麻疹(CSU)是一种令人痛苦的皮肤状况,其特征是皮肤出现红色、肿胀、瘙痒,有时还伴有疼痛性风团或荨麻疹。最近,CSU 与缓激肽释放有关,而缓激肽释放被发现是遗传性血管性水肿发作的主要诱因。为了研究缓激肽受体 1(BR1)和 2(BR2)在 CSU 发病机制中的作用。共招募了 60 名个体,其中 30 名 CSU 患者和 30 名健康受试者。CSU 是根据皮肤科皮肤症状评估的标准化方案诊断的。BR1 和 BR2 的水平在 CD3、CD4 和 CD8 淋巴细胞以及 CD14CD16、CD14CD16 和 CD14CD16 单核细胞中确定。此外,还评估了 7 天的荨麻疹活动评分总和(UAS-7),并与 BR1 和 BR2 表达相关。与对照组相比,CSU 患者的淋巴细胞中 BR1 表达浓度显著升高(<0.001)。此外,在 CD14CD16 细胞中,UAS-7 与 BR1/BR2 表达之间存在显著的正相关关系(=0.03,R=0.4)。结果表明,在有症状的 CSU 患者中,与健康对照组相比,BR1 在某些淋巴细胞亚群中的表达升高,表明其在疾病发病机制中的作用。